Tomato and lycopene supplementation and cardiovascular risk factors: A systematic review and meta-analysis

Atherosclerosis

Volumn 257, Issue , 2017, Pages 100-108

  Cheng, Ho Ming ^a   Koutsidis, Georgios ^a   Lodge, John K ^a   Ashor, Ammar ^b   Siervo, Mario ^b   Lara, José ^a  

^a NORTHUMBRIA UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Blood lipids; Blood pressure; Cardiovascular risk factors; Endothelial function; Inflammatory factors; Intervention; Lycopene; Meta analysis; Systematic review; Tomato

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; TRIACYLGLYCEROL; AUTACOID; BIOLOGICAL MARKER; CAROTENOID;

ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DATA BASE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; FLOW-MEDIATED DILATION TEST; HUMAN; LIPID BLOOD LEVEL; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE WAVE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TOMATO; ADULT; BLOOD; CARDIOVASCULAR DISEASES; CHI SQUARE DISTRIBUTION; DIETARY SUPPLEMENT; FEMALE; HEALTH STATUS; HEALTHY DIET; MALE; METABOLISM; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PROGNOSIS; PROTECTION; RISK ASSESSMENT; RISK FACTOR; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADULT; BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTENOIDS; CHI-SQUARE DISTRIBUTION; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; FEMALE; HEALTH STATUS; HEALTHY DIET; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; LYCOPERSICON ESCULENTUM; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 85010302942     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.01.009     Document Type: Article

References (45)

1. [1] Forouzanfar, M.H., Alexander, L., Anderson, H.R., Bachman, V.F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M.M., Cohen, A., et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:10010 (2015), 2287–2323.
2. [2] Mozaffarian, D., Appel, L.J., Van Horn, L., Components of a cardioprotective diet: New insights. Circulation 123:24 (2011), 2870–2891.
3. [3] Siervo, M., Lara, J., Ogbonmwan, I., Mathers, J.C., Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J. Nutr. 143:6 (2013), 818–826.
4. [4] Lara, J., Ashor, A.W., Oggioni, C., Ahluwalia, A., Mathers, J.C., Siervo, M., Effects of inorganic nitrate and beetroot supplementation on endothelial function: a systematic review and meta-analysis. Eur. J. Nutr. 55:2 (2016), 451–459.
5. [5] Sesso, H.D., Liu, S., Gaziano, J.M., Buring, J.E., Dietary lycopene, tomato-based food products and cardiovascular disease in women. J. Nutr. 133:7 (2003), 2336–2341.
6. [6] Jacques, P.F., Lyass, A., Massaro, J.M., Vasan, R.S., D'Agostino, R.B. Sr., Relationship of lycopene intake and consumption of tomato products to incident CVD. Br. J. Nutr. 110:3 (2013), 545–551.
7. [7] Mein, J.R., Lian, F., Wang, X.D., Biological activity of lycopene metabolites: implications for cancer prevention. Nutr. Rev. 66:12 (2008), 667–683.
8. [8] Higgins, J., Green, S., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Cochrane Database Syst Rev, 2011.
9. [9] University of York, Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. York, UK, 2009.
10. [10] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 8:5 (2010), 336–341.
11. [11] Egger, M., Davey Smith, G., Schneider, M., Minder C: bias in meta-analysis detected by a simple, graphical test. Bmj 315:7109 (1997), 629–634.
12. [12] Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J.M., Gavaghan, D.J., McQuay, H.J., Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin. Trials 17:1 (1996), 1–12.
13. [13] Biddle, M.J., Lennie, T.A., Bricker, G.V., Kopec, R.E., Schwartz, S.J., Moser, D.K., Lycopene dietary intervention: a pilot study in patients with heart failure. J. Cardiovasc. Nurs. 30:3 (2015), 205–212.
14. [14] Blum, A., Merei, M., Karem, A., Blum, N., Ben-Arzi, S., Wirsansky, I., Khazim, K., Effects of tomatoes on the lipid profile. Clin. Invest Med. 29:5 (2006), 298–300.
15. [15] Blum, A., Monir, M., Khazim, K., Peleg, A., Blum, N., Tomato-rich (Mediterranean) diet does not modify inflammatory markers. Clin. Investig. Med. Méd. Clin. Exp. 30:2 (2007), E70–E74.
16. [16] Burton-Freeman, B., Talbot, J., Park, E., Krishnankutty, S., Edirisinghe, I., Protective activity of processed tomato products on postprandial oxidation and inflammation: a clinical trial in healthy weight men and women. Mol. Nutr. Food Res. 56:4 (2012), 622–631.
17. [17] Collins, J.K., Arjmandi, B.H., Claypool, P.L., Perkins-Veazie, P., Baker, R.A., Clevidence, B.A., Lycopene from two food sources does not affect antioxidant or cholesterol status of middle-aged adults. Nutr. J., 3, 2004, 15.
18. [18] Cuevas-Ramos, D., Almeda-Valdés, P., Chávez-Manzanera, E., Meza-Arana, C.E., Brito-Córdova, G., Mehta, R., Pérez-Méndez, O., Gómez-Pérez, F.J., Effect of tomato consumption on high-density lipoprotein cholesterol level: a randomized, single-blinded, controlled clinical trial. Diabetes Metab. Syndr. Obes. 6 (2013), 263–273.
19. [19] Devaraj, S., Mathur, S., Basu, A., Aung, H.H., Vasu, V.T., Meyers, S., Jialal, I., A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J. Am. Coll. Nutr. 27:2 (2008), 267–273.
20. [20] Engelhard, Y.N., Gazer, B., Paran, E., Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am. Heart J., 151(1), 2006, 100 e101-100.e106.
21. [21] Gajendragadkar, P.R., Hubsch, A., Maeki-Petaejae, K.M., Serg, M., Wilkinson, I.B., Cheriyan, J., Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: a randomised controlled trial. Plos One(6), 2014, 9.
22. [22] Ghavipour, M., Saedisomeolia, A., Djalali, M., Sotoudeh, G., Eshraghyan, M.R., Moghadam, A.M., Wood, L.G., Tomato juice consumption reduces systemic inflammation in overweight and obese females. Br. J. Nutr. 109:11 (2013), 2031–2035.
23. [23] Kim, J.Y., Paik, J.K., Kim, O.Y., Park, H.W., Lee, J.H., Jang, Y., Lee, J.H., Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis 215:1 (2011), 189–195.
24. [24] Markovits, N., Ben Amotz, A., Levy, Y., The effect of tomato-derived lycopene on low carotenoids and enhanced systemic inflammation and oxidation in severe obesity. Isr. Med. Assoc. J. 11:10 (2009), 598–601.
25. [25] Misra, R., Mangi, S., Joshi, S., Mittal, S., Gupta, S.K., Pandey, R.M., LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: a randomized controlled clinical trial. J. Obstet. Gynaecol. Res. 32:3 (2006), 299–304.
26. [26] Paran, E., Novack, V., Engelhard, Y.N., Hazan-Halevy, I., The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Drugs Ther. 23:2 (2009), 145–151.
27. [27] Ried, K., Frank, O.R., Stocks, N.P., Dark chocolate or tomato extract for prehypertension: a randomised controlled trial. BMC Complement. Altern. Med., 9, 2009, 22.
28. [28] Samaras, A., Tsarouhas, K., Paschalidis, E., Giamouzis, G., Triposkiadis, F., Tsitsimpikou, C., Becker, A.T., Goutzourelas, N., Kouretas, D., Effect of a special carbohydrate-protein bar and tomato juice supplementation on oxidative stress markers and vascular endothelial dynamics in ultra-marathon runners. Food Chem. Toxicol. 69 (2014), 231–236.
29. [29] Silaste, M.L., Alfthan, G., Aro, A., Kesaniemi, Y.A., Horkko, S., Tomato juice decreases LDL cholesterol levels and increases LDL resistance to oxidation. Br. J. Nutr. 98:6 (2007), 1251–1258.
30. [30] Stangl, V., Kuhn, C., Hentschel, S., Jochmann, N., Jacob, C., Böhm, V., Fröhlich, K., Müller, L., Gericke, C., Lorenz, M., Lack of effects of tomato products on endothelial function in human subjects: results of a randomised, placebo-controlled cross-over study. Br. J. Nutr. 105:2 (2011), 263–267.
31. [31] Thies, F., Masson, L.F., Rudd, A., Vaughan, N., Tsang, C., Brittenden, J., Simpson, W.G., Duthie, S., Horgan, G.W., Duthie, G., Effect of a tomato-rich diet on markers of cardiovascular disease risk in moderately overweight, disease-free, middle-aged adults: a randomized controlled trial. Am. J. Clin. Nutr. 95:5 (2012), 1013–1022.
32. [32] Tsitsimpikou, C., Tsarouhas, K., Kioukia-Fougia, N., Skondra, C., Fragkiadaki, P., Papalexis, P., Stamatopoulos, P., Kaplanis, I., Hayes, A.W., Tsatsakis, A., et al. Dietary supplementation with tomato-juice in patients with metabolic syndrome: a suggestion to alleviate detrimental clinical factors. Food Chem. Toxicol. 74 (2014), 9–13.
33. [33] Upritchard, J.E., Sutherland, W.H.F., Mann, J.I., Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 23:6 (2000), 733–738.
34. [34] Xaplanteris, P., Vlachopoulos, C., Pietri, P., Terentes-Printzios, D., Kardara, D., Alexopoulos, N., Aznaouridis, K., Miliou, A., Stefanadis, C., Tomato paste supplementation improves endothelial dynamics and reduces plasma total oxidative status in healthy subjects. Nutr. Res. (New York, NY) 32:5 (2012), 390–394.
35. [35] Ried, K., Fakler, P., Protective effect of lycopene on serum cholesterol and blood pressure: meta-analyses of intervention trials. Maturitas 68:4 (2011), 299–310.
36. [36] Li, X., Xu, J., Lycopene supplement and blood pressure: an updated meta-analysis of intervention trials. Nutrients 5:9 (2013), 3696–3712.
37. [37] Gonzalez, M.A., Selwyn, A.P., Endothelial function, inflammation, and prognosis in cardiovascular disease. Am. J. Med. 115:Suppl 8A (2003), 99s–106s.
38. [38] Ashor, A.W., Siervo, M., van der Velde, F., Willis, N.D., Mathers, J.C., Systematic review and meta-analysis of randomised controlled trials testing the effects of vitamin C supplementation on blood lipids. Clin. Nutr. 35:3 (2016), 626–637.
39. [39] Chen, J., Song, Y., Zhang, L., Effect of lycopene supplementation on oxidative stress: an exploratory systematic review and meta-analysis of randomized controlled trials. J. Med. food 16:5 (2013), 361–374.
40. [40] Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr., Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T. Jr., et al. Seventh report of the Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:6 (2003), 1206–1252.
41. [41] Reboldi, G., Gentile, G., Angeli, F., Ambrosio, G., Mancia, G., Verdecchia, P., Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J. Hypertens. 29:7 (2011), 1253–1269.
42. [42] Baigent, C., Keech, A., Kearney, P.M., Blackwell, L., Buck, G., Pollicino, C., Kirby, A., Sourjina, T., Peto, R., Collins, R., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:9493 (2005), 1267–1278.
43. [43] Inaba, Y., Chen, J.A., Bergmann, S.R., Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int. J. Cardiovasc Imaging 26:6 (2010), 631–640.
44. [44] Xu, Y., Arora, R.C., Hiebert, B.M., Lerner, B., Szwajcer, A., McDonald, K., Rigatto, C., Komenda, P., Sood, M.M., Tangri, N., Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. Eur. Heart J. Cardiovasc Imaging 15:7 (2014), 736–746.
45. [45] Matsuzawa, Y., Kwon, T.G., Lennon, R.J., Lerman, L.O., Lerman, A., Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J. Am. Heart Assoc.(11), 2015, 4.